ARID1A and cancer: Additionally, the EZH2/PTEN/E2F1 axis is involved in the regulation of MDM2 expression, and MDM2 expression is upregulated in ARID1A deficient cancers via this axis, which promotes MDM2-mediated P53 degradation and exacerbates the malignant phenotype of these cancers.